McArthur GA - Search Results

1

BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid Carcinoma.

Lim AM, Taylor GR, Fellowes A, Cameron L, Lee B, Hicks RJ, McArthur GA, Angel C, Solomon B, Rischin D. Lim AM, et al. Among authors: mcarthur ga. J Natl Compr Canc Netw. 2016 Mar;14(3):249-54. doi: 10.6004/jnccn.2016.0030. Epub 2016 Mar 8. J Natl Compr Canc Netw. 2016. PMID: 26957611

2

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia.

Rosenthal MA, Rischin D, McArthur G, Ribbons K, Chong B, Fareed J, Toner G, Green MD, Basser RL. Rosenthal MA, et al. Ann Oncol. 2002 May;13(5):770-6. doi: 10.1093/annonc/mdf117. Ann Oncol. 2002. PMID: 12075747 Free article. Clinical Trial.

3

EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor.

Solomon B, Hagekyriakou J, Trivett MK, Stacker SA, McArthur GA, Cullinane C. Solomon B, et al. Among authors: mcarthur ga. Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):713-23. doi: 10.1016/s0360-3016(02)04357-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573759

4

Applications of positron emission tomography in the development of molecular targeted cancer therapeutics.

Solomon B, McArthur G, Cullinane C, Zalcberg J, Hicks R. Solomon B, et al. BioDrugs. 2003;17(5):339-54. doi: 10.2165/00063030-200317050-00004. BioDrugs. 2003. PMID: 14498764 Review.

5

Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.

Solomon B, Binns D, Roselt P, Weibe LI, McArthur GA, Cullinane C, Hicks RJ. Solomon B, et al. Among authors: mcarthur ga. Mol Cancer Ther. 2005 Sep;4(9):1417-22. doi: 10.1158/1535-7163.MCT-05-0066. Mol Cancer Ther. 2005. PMID: 16170034

6

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.

Cullinane C, Dorow DS, Kansara M, Conus N, Binns D, Hicks RJ, Ashman LK, McArthur GA, Thomas DM. Cullinane C, et al. Among authors: mcarthur ga. Cancer Res. 2005 Nov 1;65(21):9633-6. doi: 10.1158/0008-5472.CAN-05-2285. Cancer Res. 2005. PMID: 16266981 Free article.

7

Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.

Dorow DS, Cullinane C, Conus N, Roselt P, Binns D, McCarthy TJ, McArthur GA, Hicks RJ. Dorow DS, et al. Among authors: mcarthur ga. Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):441-52. doi: 10.1007/s00259-005-0039-5. Epub 2006 Feb 1. Eur J Nucl Med Mol Imaging. 2006. PMID: 16450138

8

Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.

Liu W, Kelly JW, Trivett M, Murray WK, Dowling JP, Wolfe R, Mason G, Magee J, Angel C, Dobrovic A, McArthur GA. Liu W, et al. Among authors: mcarthur ga. J Invest Dermatol. 2007 Apr;127(4):900-5. doi: 10.1038/sj.jid.5700632. Epub 2006 Dec 7. J Invest Dermatol. 2007. PMID: 17159915 Free article.

9

Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease.

McArthur GA. McArthur GA. J Natl Compr Canc Netw. 2007 May;5(5):557-62. doi: 10.6004/jnccn.2007.0049. J Natl Compr Canc Netw. 2007. PMID: 17509258 Review.

10

The promise of PET in clinical management and as a sensitive test for drug cytotoxicity in sarcomas.

Khamly KK, Hicks RJ, McArthur GA, Thomas DM. Khamly KK, et al. Among authors: mcarthur ga. Expert Rev Mol Diagn. 2008 Jan;8(1):105-19. doi: 10.1586/14737159.8.1.105. Expert Rev Mol Diagn. 2008. PMID: 18088235 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page